Recall of CardioTek EPTracer

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by CardioTek BV.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    77025
  • Event Risk Class
    Class 2
  • Event Number
    Z-2657-2017
  • Event Initiated Date
    2017-04-13
  • Event Status
    Open, Classified
  • Event Country
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Computer, diagnostic, programmable - Product Code DQK
  • Reason
    Software bug which allows parameters to be changed unintentionally during use.
  • Action
    The Firm, Schwarzer cardiotek, sent an "Urgent Field Safety Notice" dated 4/21/2017 to its consignees. The notice described the product, problem and actions to be taken. The consignees were instructed to do the following: " While backup pacing is active the software must not be operated. " In case of backup pacing disconnect all catheter connection pins and reconnect only the two required for stimulation to the dedicated backup pacing output ports (OUT1 or OUT2). " If the backup pacing parameters were changed by accident quickly switch backup pacing off and on again to reset the parameters. " Ensure that the system is only operated by trained users. The firm plans to do the following: " provide an amendment to the hardware manual concerning the correct use of the backup pacing functionality to all service partners and customers. An updated software, which prevents accidental change of backup pacing parameters will be made available. Upon receipt of the amendment and installation of the software update, the completed feedback form must be returned to CardioTek no later than 3/4/2018 by fax +49 7131 2774 590 or email: Service@schwarzercardiotek.com. If you have any questions, please contact Sales & Service at +49 172 790 9112 or email: Service@schwarzercardiotek.com.

Device

  • Model / Serial
    All EP-Tracer -FSCA-identifier (2017-04-06)
  • Product Classification
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    Worldwide Distribution: US (nationwide) to states of: CA, IL, OH, and MN; and countries of: Albania, Algeria, Argentina, Bangladesh, Belgium, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Czech Rep, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Honduras, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kosovo, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malaysia, Malta, Mexico, Monaco, Morocco, Netherlands, Norway, Pakistan, Palestine, Peru, Philippines, Poland, Portugal, Rep. Dominicana, Romania, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syria, Trinidad & Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela and Vietnam.
  • Product Description
    CardioTek EP-TRACER Software V1.x and V2.0 || The EP-TRACER System is an electrophysiology measurement system used to acquire, filter, digitize, amplify, display, and record signals obtained during electrophysiological studies and related procedures. The system allows the user to monitor, display and record the signals. The system incorporates a stimulator intended to be used for diagnostic cardiac stimulation during electrophysiological testing of the heart.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    CardioTek BV, Amerikalaan 70, Maastricht-Airport Netherlands
  • Source
    USFDA